Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older

PHN risk was higher in women and increased with age and comorbidities. At least 32% and 7% of people will develop HZ and PHN, respectively, between ages 50-90 years. These results should be considered for vaccine policy implementation.